Association/NN
of/IN
glucocorticoid/NN
insensitivity/NN
with/IN
increased/VBN
expression/NN
of/IN
glucocorticoid/NN
receptor/NN
beta/NN
./.

In/IN
many/JJ
chronic/JJ
inflammatory/JJ
disorders/NNS
,/,
glucocorticoid/NN
(/(
GC/NN
)/)
insensitivity/NN
is/VBZ
a/DT
challenging/JJ
clinical/JJ
problem/NN
associated/VBN
with/IN
life-threatening/JJ
disease/NN
progression/NN
./.
=====
The/DT
molecular/JJ
basis/NN
of/IN
GC/NN
insensitivity/NN
,/,
however/RB
,/,
is/VBZ
unknown/JJ
./.
=====
Alternative/JJ
splicing/NN
of/IN
the/DT
GC/NN
receptor/NN
(/(
R/NN
)/)
pre-messenger/NN
RNA/NN
generates/VBZ
a/DT
second/JJ
GCR/NN
,/,
termed/VBN
GCR-beta/NN
,/,
which/WDT
does/VBZ
not/RB
bind/VB
GCs/NNS
but/CC
antagonizes/VBZ
the/DT
transactivating/NN
activity/NN
of/IN
the/DT
classic/JJ
GCR/NN
,/,
termed/VBN
GCR-alpha/NN
./.
=====
In/IN
the/DT
current/JJ
study/NN
,/,
we/PRP
demonstrate/VBP
that/IN
GC-insensitive/JJ
asthma/NN
is/VBZ
associated/VBN
with/IN
a/DT
significantly/RB
higher/JJR
number/NN
of/IN
GCR-beta-immunoreactive/JJ
cells/NNS
in/IN
peripheral/JJ
blood/NN
than/IN
GC-sensitive/JJ
asthmatics/NNS
or/CC
normal/JJ
controls/NNS
./.
=====
Furthermore/RB
,/,
we/PRP
show/VBP
that/IN
patients/NNS
with/IN
GC-insensitive/JJ
asthma/NN
have/VBP
cytokine-induced/JJ
abnormalities/NNS
in/IN
the/DT
DNA/NN
binding/NN
capability/NN
of/IN
the/DT
GCR/NN
./.
=====
These/DT
abnormalities/NNS
can/MD
be/VB
reproduced/VBN
by/IN
transfection/NN
of/IN
cell/NN
lines/NNS
with/IN
the/DT
GCR-beta/NN
gene/NN
resulting/VBG
in/IN
significant/JJ
reduction/NN
of/IN
their/PRP$
GCR-alpha/NN
DNA/NN
binding/NN
capacity/NN
./.
=====
We/PRP
conclude/VBP
that/IN
increased/VBN
expression/NN
of/IN
GCR-beta/NN
is/VBZ
cytokine/NN
inducible/JJ
and/CC
may/MD
account/VB
for/IN
GC/NN
insensitivity/NN
in/IN
this/DT
common/JJ
inflammatory/JJ
condition/NN
./.